Fouad Namouni Blueprint Medicines Corp (BPMC) insider trading activity
Fouad Namouni is PRESIDENT, R & D of Blueprint Medicines Corp. Currently has a direct ownership of 72,703 shares of BPMC, which is worth approximately $6.27 Million. The most recent transaction as insider was on Mar 07, 2024, when has been sold 4,377 shares (Common Stock) at a price of $90.69 per share, resulting in proceeds of $396,950. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
72.7K
0%
3M change
10.41%
12M change
Total Value Held
$6.27 Million
Fouad Namouni Transaction History
Also insider at
FN
Fouad Namouni
PRESIDENT, R & D
Cambridge, MA